Work

Faculty Opinions recommendation of Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer.

Year: 2023

Type: peer-review

Source: Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

DOI: 10.3410/f.738043592.793597758

Author: Jaffer Ajani

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Gastric Cancer Management and Outcomes

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4319746345

Cites:

Cited by:

Related to: 10